Evaluation of Risk Factors for Exacerbations in Children with Adenoviral Pneumonia

Abstract EN

Purpose.

The aim of this work was to analyze clinical features and laboratory findings of children with adenovirus pneumonia and guide clinical diagnosis, treatment, and assessment of disease severity.

Material and Methods.

Retrospective analysis of clinical data of 285 children with adenoviral pneumonia who were hospitalized in Wuhan Children’s Hospital from December 2018 to October 2019.

According to the assessment criteria for severe pneumonia, it was divided into the severe group (92 cases) and the nonsevere group (193 cases).

Collected clinical manifestations, complications, and laboratory test indicators in two groups of children and conducted all statistical analyses.

Results.

The risk of fever and wheezing was significantly higher in the severe group than in the nonsevere group.

The difference was statistically significant (P<0.05).

The risk of complications in the severe group was significantly higher than that in the nonsevere group.

The difference was statistically significant (P<0.05).

The levels of AST, LDH-L, PCT, ferritin, and D-dimer in the severe group were significantly higher than those in the nonsevere group.

The difference was statistically significant (P<0.05).

Conclusion.

Children with severe adenovirus pneumonia have severe clinical manifestations and many complications.

AST, LDH-L, PCT, ferritin, and D-dimer levels have important clinical implications for assessing disease severity.